These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24326283)

  • 1. In reply.
    Urushihara H
    Menopause; 2014 Jan; 21(1):110. PubMed ID: 24326283
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Raloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillance.
    Hamaya E; Sowa H
    Menopause; 2014 Jan; 21(1):109-10. PubMed ID: 24281238
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypocalcemia induced by raloxifene.
    Vu TD; Varadarajan S; Seeman E; Jerums G; MacIsaac RJ
    Curr Drug Saf; 2012 Apr; 7(2):176-8. PubMed ID: 22873502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A postmenopausal woman developed a giant endometrial polyp during Raloxifene treatment.
    Kutuk MS; Goksedef BP
    J Obstet Gynaecol; 2011 Oct; 31(7):672. PubMed ID: 21973134
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance study.
    Takeuchi Y; Hamaya E; Taketsuna M; Sowa H
    Menopause; 2015 Oct; 22(10):1134-7. PubMed ID: 25756692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus in women can be RUTHless: lessons from the Raloxifene Use for The Heart (RUTH) Trial.
    Budoff MJ
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):137-8. PubMed ID: 23481520
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.
    Nagatoya K; Nishimoto K; Shibahara N; Takahashi T; Kanehara H; Ueno N; Yasuda H; Okada S; Ueda H; Hirai K; Inoue T;
    Clin Exp Nephrol; 2015 Oct; 19(5):939-46. PubMed ID: 25504368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid artery intima-media thickness after raloxifene treatment.
    Mack WJ; Dhungana B; Dowsett SA; Keech CA; Feng M; Li Y; Hodis HN
    J Womens Health (Larchmt); 2007 Apr; 16(3):370-8. PubMed ID: 17439382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of comparative effectiveness of treatments to prevent fractures.
    Stock JL; Mershon JL; Schoenfeld MJ
    Ann Intern Med; 2008 Jun; 148(11):885; author reply 887. PubMed ID: 18519941
    [No Abstract]   [Full Text] [Related]  

  • 10. Raloxifene vs tamoxifen.
    Goldstein SR
    JAMA; 2007 Jan; 297(3):263-4; author reply 264. PubMed ID: 17227974
    [No Abstract]   [Full Text] [Related]  

  • 11. Mandibular Osteonecrosis Associated With Raloxifene.
    Pontes HAR; Souza LL; Uchôa DCC; Cerqueira JMM
    J Craniofac Surg; 2018 May; 29(3):e257-e259. PubMed ID: 29303860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillance.
    Urushihara H; Kikuchi N; Yamada M; Yoshiki F; Miyauchi A
    Menopause; 2009; 16(5):971-7. PubMed ID: 19357545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. My doctor wanted me to start taking Evista (raloxifene hydrochloride) for osteoporosis, but I'm worried because the drug is linked to a risk of blood clots. I have mild hypertension that I manage with medications, diet and exercise. Do you think the drug is safe?
    Heart Advis; 2010 May; 13(5):8. PubMed ID: 22816154
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Dec; 59(1536):203-210. PubMed ID: 29232356
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison table: some drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Jun; 59(1523):e104-e106. PubMed ID: 28609428
    [No Abstract]   [Full Text] [Related]  

  • 16. Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).
    Fujiwara S; Hamaya E; Sato M; Graham-Clarke P; Flynn JA; Burge R
    Clin Interv Aging; 2014; 9():1879-93. PubMed ID: 25395843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison table: Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Dec; 59(1536):e210-e212. PubMed ID: 29232357
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous reports of pulmonary embolism in association with raloxifene.
    Brinker A; Beitz J
    Obstet Gynecol; 2001 Dec; 98(6):1151. PubMed ID: 11755578
    [No Abstract]   [Full Text] [Related]  

  • 19. [What can we expect of raloxifene in the treatment of postmenopausal osteoporosis--views of a gynecologist].
    Chmel R; Rob L; Strnad P
    Ceska Gynekol; 2002 Jul; 67(4):187-91. PubMed ID: 12373918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abaloparatide (Tymlos) for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Jun; 59(1523):97-98. PubMed ID: 28609423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.